Sponsored - Labiotech.eu https://www.labiotech.eu/partner/ The European Biotech News Website Mon, 10 Jul 2023 21:22:46 +0000 en-US hourly 1 https://wordpress.org/?v=6.1.1 https://www.labiotech.eu/wp-content/uploads/2020/04/cropped-favicon-32x32.png Sponsored - Labiotech.eu https://www.labiotech.eu/partner/ 32 32 How to select the right CDMO for innovative antibody development https://www.labiotech.eu/partner/cdmo-antibody-development-kbi-biopharma/ https://www.labiotech.eu/partner/cdmo-antibody-development-kbi-biopharma/#respond Tue, 11 Jul 2023 08:00:05 +0000 https://www.labiotech.eu/?p=118880 The post How to select the right CDMO for innovative antibody development appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/cdmo-antibody-development-kbi-biopharma/feed/ 0
How to find lab space as a startup https://www.labiotech.eu/partner/lab-space-startup-smart-lab-architects/ https://www.labiotech.eu/partner/lab-space-startup-smart-lab-architects/#respond Tue, 27 Jun 2023 08:00:34 +0000 https://www.labiotech.eu/?p=118515 The post How to find lab space as a startup appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/lab-space-startup-smart-lab-architects/feed/ 0
How to accelerate your biotherapeutics’ path to clinic https://www.labiotech.eu/partner/strategies-accelerate-biotherapeutics-to-clinic-lonza/ https://www.labiotech.eu/partner/strategies-accelerate-biotherapeutics-to-clinic-lonza/#respond Wed, 21 Jun 2023 08:00:09 +0000 https://www.labiotech.eu/?p=118456 The post How to accelerate your biotherapeutics’ path to clinic appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/strategies-accelerate-biotherapeutics-to-clinic-lonza/feed/ 0
Sub-$100 genome sequencing the highlight of Complete Genomics’ 18th anniversary milestone https://www.labiotech.eu/partner/genome-sequencing-complete-genomics/ https://www.labiotech.eu/partner/genome-sequencing-complete-genomics/#respond Thu, 15 Jun 2023 08:00:22 +0000 https://www.labiotech.eu/?p=118286 The post Sub-$100 genome sequencing the highlight of Complete Genomics’ 18th anniversary milestone appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/genome-sequencing-complete-genomics/feed/ 0
Optimizing early discovery by unraveling cancer complexity within precision therapeutics https://www.labiotech.eu/partner/precision-medicine-nravel-early-oncology-discovery/ https://www.labiotech.eu/partner/precision-medicine-nravel-early-oncology-discovery/#respond Tue, 06 Jun 2023 08:00:05 +0000 https://www.labiotech.eu/?p=117686 The post Optimizing early discovery by unraveling cancer complexity within precision therapeutics appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/precision-medicine-nravel-early-oncology-discovery/feed/ 0
Assessing the EU Pharmaceutical Package – Positives, negatives and the impact on smaller pharma and biotech companies https://www.labiotech.eu/partner/eu-pharmaceutical-package-2023-eucope/ https://www.labiotech.eu/partner/eu-pharmaceutical-package-2023-eucope/#respond Tue, 30 May 2023 08:00:05 +0000 https://www.labiotech.eu/?p=117059 The post Assessing the EU Pharmaceutical Package – Positives, negatives and the impact on smaller pharma and biotech companies appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/eu-pharmaceutical-package-2023-eucope/feed/ 0
20 years of BIOSPAIN – The evolution of an international biotech event https://www.labiotech.eu/partner/asebio-biospain-2023/ https://www.labiotech.eu/partner/asebio-biospain-2023/#respond Tue, 23 May 2023 08:00:46 +0000 https://www.labiotech.eu/?p=116915 The post 20 years of BIOSPAIN – The evolution of an international biotech event appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/asebio-biospain-2023/feed/ 0
Report: Outsourcing in Life Science R&D Today https://www.labiotech.eu/partner/outsourcing-in-life-science-research-development/ Tue, 16 May 2023 10:21:25 +0000 https://www.labiotech.eu/?p=117079 Over the last twenty years, life science companies started outsourcing large portions of their R&D activities to external suppliers, including complex, specialized services that were traditionally performed in-house. Outsourcing has become an integral part of life science R&D over the last two decades. There are several reasons for this shift. The cost of drug development […]

The post Report: Outsourcing in Life Science R&D Today appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
Separation and analysis of empty and filled capsids during viral vector production https://www.labiotech.eu/partner/separation-analysis-aav-capsids-merck/ https://www.labiotech.eu/partner/separation-analysis-aav-capsids-merck/#respond Tue, 09 May 2023 08:00:21 +0000 https://www.labiotech.eu/?p=116907 The post Separation and analysis of empty and filled capsids during viral vector production appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/separation-analysis-aav-capsids-merck/feed/ 0
How is Quantoom Biosciences’ Ntensify™ technology changing mRNA production? https://www.labiotech.eu/partner/quantoom-ntensify-mrna/ https://www.labiotech.eu/partner/quantoom-ntensify-mrna/#respond Thu, 04 May 2023 08:00:59 +0000 https://www.labiotech.eu/?p=116499 The post How is Quantoom Biosciences’ Ntensify™ technology changing mRNA production? appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/quantoom-ntensify-mrna/feed/ 0
Becoming human: GMP-compliant supplements for cell therapy https://www.labiotech.eu/partner/pl-bioscience-elarem-gmp-cell-therapy/ https://www.labiotech.eu/partner/pl-bioscience-elarem-gmp-cell-therapy/#respond Tue, 25 Apr 2023 08:00:20 +0000 https://www.labiotech.eu/?p=116277 The post Becoming human: GMP-compliant supplements for cell therapy appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/pl-bioscience-elarem-gmp-cell-therapy/feed/ 0
8 life science innovators you must meet at BioTrinity 2023 https://www.labiotech.eu/partner/biotrinity-2023-france/ https://www.labiotech.eu/partner/biotrinity-2023-france/#respond Thu, 20 Apr 2023 08:00:19 +0000 https://www.labiotech.eu/?p=116223 The post 8 life science innovators you must meet at BioTrinity 2023 appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/biotrinity-2023-france/feed/ 0
Opna Bio establishes CDD Vault as central repository for preclinical data https://www.labiotech.eu/partner/opna-bio-cdd-vault-oncology/ https://www.labiotech.eu/partner/opna-bio-cdd-vault-oncology/#respond Tue, 18 Apr 2023 08:00:06 +0000 https://www.labiotech.eu/?p=114431 The post Opna Bio establishes CDD Vault as central repository for preclinical data appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/opna-bio-cdd-vault-oncology/feed/ 0
Protein particle characterization: Challenges and future trends https://www.labiotech.eu/partner/protein-particle-characterization-bionter/ https://www.labiotech.eu/partner/protein-particle-characterization-bionter/#respond Tue, 04 Apr 2023 08:00:14 +0000 https://www.labiotech.eu/?p=115451 The post Protein particle characterization: Challenges and future trends appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/protein-particle-characterization-bionter/feed/ 0
BIO-Europe Spring 2023: The Highlights https://www.labiotech.eu/partner/bio-europe-spring-2023/ https://www.labiotech.eu/partner/bio-europe-spring-2023/#respond Mon, 03 Apr 2023 09:00:51 +0000 https://www.labiotech.eu/?p=115571 BIO-Europe Spring is one of Europe’s biggest biotech partnering events with discussion topics ranging from platform technologies and manufacturing to biotech investments. Here are some of the key take-home reports from the proceedings. The event, which took place from March 20 to 22, in the budding biotech hub of Basel, Switzerland, was in full swing […]

The post BIO-Europe Spring 2023: The Highlights appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/bio-europe-spring-2023/feed/ 0
Infographic: Why choosing a client-centric CTDMO is critical when outsourcing biomanufacturing projects https://www.labiotech.eu/partner/ctdmo-biomanufacturing-biologics-merck/ https://www.labiotech.eu/partner/ctdmo-biomanufacturing-biologics-merck/#respond Tue, 28 Mar 2023 08:00:29 +0000 https://www.labiotech.eu/?p=106795 In 2021, 28% of FDA approvals were granted to biologic drugs, showcasing the increasing demand for the biopharma industry to develop, manufacture and market biologic-based therapies. Biologic drugs include monoclonal antibodies and large molecules produced in mammalian cells, bringing the already complex process of drug development to a new level. Although the biomanufacturing of many […]

The post Infographic: Why choosing a client-centric CTDMO is critical when outsourcing biomanufacturing projects appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/ctdmo-biomanufacturing-biologics-merck/feed/ 0
Streamlining supplier qualification with a more efficient on-site pre-assessment process https://www.labiotech.eu/partner/supplier-pre-assessments-verifi/ https://www.labiotech.eu/partner/supplier-pre-assessments-verifi/#respond Wed, 22 Mar 2023 09:00:55 +0000 https://www.labiotech.eu/?p=114620 The post Streamlining supplier qualification with a more efficient on-site pre-assessment process appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/supplier-pre-assessments-verifi/feed/ 0
Nurturing healthcare innovation: a multi-disciplinary ecosystem to overcome startup challenges https://www.labiotech.eu/partner/health-innovation-startups-uk-phta/ https://www.labiotech.eu/partner/health-innovation-startups-uk-phta/#respond Tue, 14 Mar 2023 09:00:20 +0000 https://www.labiotech.eu/?p=114318 The Covid-19 pandemic highlighted the importance of innovation in the healthcare space when tackling a public health challenge. Nonetheless, health innovation startups today face multiple hurdles, from sourcing funding, to obtaining access to the right expertise, and more. Of late, an additional hurdle that young life science businesses also have to contend with is the […]

The post Nurturing healthcare innovation: a multi-disciplinary ecosystem to overcome startup challenges appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/health-innovation-startups-uk-phta/feed/ 0
Meet some of the biotechs attending Bio-Europe Spring 2023 https://www.labiotech.eu/partner/biotech-companies-bio-europe-spring-2023/ https://www.labiotech.eu/partner/biotech-companies-bio-europe-spring-2023/#respond Fri, 10 Mar 2023 09:00:03 +0000 https://www.labiotech.eu/?p=114174 As Bio-Europe Spring 2023 is set to take place from March 20 to March 22 in Basel, Switzerland, a budding biotech hub, the event will provide opportunities to engage with representatives of hundreds of companies from around the world.  At the convention, exhibitors will be able to showcase their innovations and meet with prospective sponsors, […]

The post Meet some of the biotechs attending Bio-Europe Spring 2023 appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/biotech-companies-bio-europe-spring-2023/feed/ 0
Pharma services companies you should know about at Bio-Europe Spring 2023 https://www.labiotech.eu/partner/pharma-services-companies-bio-europe-spring-2023/ https://www.labiotech.eu/partner/pharma-services-companies-bio-europe-spring-2023/#respond Thu, 09 Mar 2023 09:00:44 +0000 https://www.labiotech.eu/?p=114159 Bio-Europe Spring 2023, which takes place March 20-22 in Basel, Switzerland, is the largest gathering of biopharma professionals in Europe. It presents an opportunity for companies from around the world to engage in face-to-face meetings and facilitate partnerships. Alongside networking, there will also be workshops, panels, exhibitions, and a variety of company presentations. The keynote […]

The post Pharma services companies you should know about at Bio-Europe Spring 2023 appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>
https://www.labiotech.eu/partner/pharma-services-companies-bio-europe-spring-2023/feed/ 0